References
- Torun MT, Unver E, Yalcin Y, et al. The importance of calprotectin levels in obstructive sleep apnea syndrome severity. Curr Med Res Opin 2017: published online 18 October 2017, doi: 10.1080/03007995.2017.138390
- Mariani A, Marsili M, Nozzi M, et al. Serum calprotectin: review of its usefulness and validity in paediatric rheumatic diseases. Clin Exp Rheumatol 2015;33:109-14
- Pedersen L, Nybo M, Poulsen MK, et al. Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients. BMC Cardiovasc Disord 2014;14:196
- Liosi S, Briana DD, Gourgiotis D, et al. Calprotectin in human cord blood: relation to perinatal parameters and restricted fetal growth. J Perinat Med 2010;38:523-6
- Unic-Stojanovic D, Isenovic ER, Jovic M, et al. Copeptin levels do not correlate with cross-clamping time in patients undergoing carotid endarterectomy under general anesthesia. Angiology 2016;67:951-60
- Paraskevas KI, Briana DD, Malamitsi-Puchner A. Copeptin for all. Angiology 2016;67:894-5
- Briana DD, Malamitsi-Puchner A. Developmental origins of adult health and disease: the metabolic role of BDNF from early life to adulthood. Metabolism 2017: published online 4 December 2017, doi: 10.1016/j.metabol.2017.11.09
- Barker DJ. In utero programming of chronic disease. Clin Sci (Lond) 1998;95:115-28